Lanzhou a light curing initiator and intermediate project with an annual output of 1200 tons is located in provincial chemical park, high tech Zone, Baiyin City, Gansu Province. The project covers an area of 53333.3m2 and has a total investment of 165 million yuan (26 millionusd). It is committed to the R & D, production and sales of high-end fine chemicals and intermediate materials, so as to build a first-class modern fine chemical enterprise in China.
2. Main products
Phase I of the project will build a production line with an annual output of 400 tons of light curing initiator (300t / a light curing initiator 369, 100t / a light curing initiator 2959) and an annual output of 300 tons of intermediate products (200t / a brominated polymer 8104, 50t / a 4, 4 '- dihydroxydiphenyl ether, 50t / a camphenyl chloride). 127 / camphoric acid / tetrapropionic acid, etc.
3. Advantageous technologies
Friedel-Crafts reaction, bromination reaction, catalytic hydrogenation, amination reaction, high temperature and high pressure, hydrogenation reaction of nitrobenzene analogues, chlorination reaction (sulfonyl chloride/thionyl chloride/phosphorus oxychloride/phosphorus pentachloride) .
4. R & D team
The company has a public technical service platform, a pilot scale-up base, and a laboratory area of 500 square meters. The company focuses on technological innovation and product research and development. In 2021, it will introduce 3 high-level talents, 35 existing technical talents, and 15 independent intellectual property rights. ,
Established an analysis and testing center, with more than 30 sets of domestic advanced experimental analysis equipment. Ensure comprehensive, strict and effective quality control of products, ensure that products meet international first-class standards, and formulate new corporate standards.
5. Cooperation needs
(1) Sales mode of initiator products: looking for end customers forUVB coating, UV ink and other product manufacturers;
(2) Sales mode of intermediate products: seek customers of pharmaceutical intermediates, realize customized entrusted production through CMO mode, and realize the strategic partner of R & D, production and sales integration.
6. Future planning
Based on the global operation and development strategy and based on the field of photoinitiators, the company implements the product diversification development strategy and actively expands the field of light curing new materials and pharmaceutical intermediates. Focusing on the existing products and market, the company will gradually increase the R & D, production and sales of high-end photoinitiators, electronic chemicals, pharmaceutical intermediates and other materials, constantly enrich the company's product structure, further expand the market share, enhance the company's comprehensive competitive advantage, and build the company into a specialized and new enterprise in the global UV curing industry.